Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

Literature DB >> 24323992

First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

Antoine Ittel¹, Eric Jeandidier, Catherine Helias, Nathalie Perrusson, Catherine Humbrecht, Bruno Lioure, Isabelle Mazurier, Caroline Mayeur-Rousse, Amandine Lavaux, Sylvie Thiebault, Felix Lerintiu, Carine Gervais, Laurent Mauvieux.
1. mauvieux@unistra.fr.

Abstract

Entities: Disease Gene

Keywords: MLL-TET1; leukemia; lineage switch

Mesh：

Substances：

Year: 2013 PMID： 24323992 PMCID： PMC3856982 DOI： 10.3324/haematol.2013.096750

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

14 in total

1. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

Authors: R B Lorsbach; J Moore; S Mathew; S C Raimondi; S T Mukatira; J R Downing
Journal: Leukemia Date: 2003-03 Impact factor: 11.528

2. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement.

Authors: L-Y Shih; D-C Liang; J-F Fu; J-H Wu; P-N Wang; T-L Lin; P Dunn; M-C Kuo; T-C Tang; T-H Lin; C-L Lai
Journal: Leukemia Date: 2006-02 Impact factor: 11.528

3. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.

Authors: Sang-Guk Lee; Sun Young Cho; Min Jin Kim; Seung Hwan Oh; Eun Hae Cho; Sanggyu Lee; Eun Jung Baek; Jung Hye Choi; Stefan K Bohlander; Laurence Lode; Steven Richebourg; Hwi-Joong Yoon; Rolf Marschalek; Claus Meyer; Tae Sung Park
Journal: Haematologica Date: 2012-10-25 Impact factor: 9.941

4. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

Authors: Kian Peng Koh; Akiko Yabuuchi; Sridhar Rao; Yun Huang; Kerrianne Cunniff; Julie Nardone; Asta Laiho; Mamta Tahiliani; Cesar A Sommer; Gustavo Mostoslavsky; Riitta Lahesmaa; Stuart H Orkin; Scott J Rodig; George Q Daley; Anjana Rao
Journal: Cell Stem Cell Date: 2011-02-04 Impact factor: 24.633

5. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).

Authors: Ryoichi Ono; Tomohiko Taki; Takeshi Taketani; Masafumi Taniwaki; Hajime Kobayashi; Yasuhide Hayashi
Journal: Cancer Res Date: 2002-07-15 Impact factor: 12.701

6. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

Authors: Thomas Burmeister; Claus Meyer; Stefan Schwartz; Julia Hofmann; Mara Molkentin; Eric Kowarz; Björn Schneider; Thorsten Raff; Richard Reinhardt; Nicola Gökbuget; Dieter Hoelzer; Eckhard Thiel; Rolf Marschalek
Journal: Blood Date: 2009-01-14 Impact factor: 22.113

7. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.

Authors: M J Thirman; H J Gill; R C Burnett; D Mbangkollo; N R McCabe; H Kobayashi; S Ziemin-van der Poel; Y Kaneko; R Morgan; A A Sandberg
Journal: N Engl J Med Date: 1993-09-23 Impact factor: 91.245

8. The MLL recombinome of acute leukemias in 2013.

Authors: C Meyer; J Hofmann; T Burmeister; D Gröger; T S Park; M Emerenciano; M Pombo de Oliveira; A Renneville; P Villarese; E Macintyre; H Cavé; E Clappier; K Mass-Malo; J Zuna; J Trka; E De Braekeleer; M De Braekeleer; S H Oh; G Tsaur; L Fechina; V H J van der Velden; J J M van Dongen; E Delabesse; R Binato; M L M Silva; A Kustanovich; O Aleinikova; M H Harris; T Lund-Aho; V Juvonen; O Heidenreich; J Vormoor; W W L Choi; M Jarosova; A Kolenova; C Bueno; P Menendez; S Wehner; C Eckert; P Talmant; S Tondeur; E Lippert; E Launay; C Henry; P Ballerini; H Lapillone; M B Callanan; J M Cayuela; C Herbaux; G Cazzaniga; P M Kakadiya; S Bohlander; M Ahlmann; J R Choi; P Gameiro; D S Lee; J Krauter; P Cornillet-Lefebvre; G Te Kronnie; B W Schäfer; S Kubetzko; C N Alonso; U zur Stadt; R Sutton; N C Venn; S Izraeli; L Trakhtenbrot; H O Madsen; P Archer; J Hancock; N Cerveira; M R Teixeira; L Lo Nigro; A Möricke; M Stanulla; M Schrappe; L Sedék; T Szczepański; C M Zwaan; E A Coenen; M M van den Heuvel-Eibrink; S Strehl; M Dworzak; R Panzer-Grümayer; T Dingermann; T Klingebiel; R Marschalek
Journal: Leukemia Date: 2013-04-30 Impact factor: 11.528

9. Lineage switching in acute leukemias: a consequence of stem cell plasticity?

Authors: Elisa Dorantes-Acosta; Rosana Pelayo
Journal: Bone Marrow Res Date: 2012-07-19

10. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.

Authors: Yael Costa; Junjun Ding; Thorold W Theunissen; Francesco Faiola; Timothy A Hore; Pavel V Shliaha; Miguel Fidalgo; Arven Saunders; Moyra Lawrence; Sabine Dietmann; Satyabrata Das; Dana N Levasseur; Zhe Li; Mingjiang Xu; Wolf Reik; José C R Silva; Jianlong Wang
Journal: Nature Date: 2013-02-10 Impact factor: 49.962

12 in total

1. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.

Authors: Hyeng-Soo Kim; Seung Hwan Oh; Ju-Heon Kim; Jae-Young Kim; Do-Hyung Kim; Soo-Jin Lee; Sang-Un Choi; Kwon Moo Park; Zae Young Ryoo; Tae Sung Park; Sanggyu Lee
Journal: Haematologica Date: 2017-08-10 Impact factor: 9.941

2. The Impact of DNA Methylation in Hematopoietic Malignancies.

Authors: Maria Guillamot; Luisa Cimmino; Iannis Aifantis
Journal: Trends Cancer Date: 2016-02-01

3. TET1 is a tumor suppressor of hematopoietic malignancy.

Authors: Luisa Cimmino; Meelad M Dawlaty; Delphine Ndiaye-Lobry; Yoon Sing Yap; Sofia Bakogianni; Yiting Yu; Sanchari Bhattacharyya; Rita Shaknovich; Huimin Geng; Camille Lobry; Jasper Mullenders; Bryan King; Thomas Trimarchi; Beatriz Aranda-Orgilles; Cynthia Liu; Steven Shen; Amit K Verma; Rudolf Jaenisch; Iannis Aifantis
Journal: Nat Immunol Date: 2015-04-13 Impact factor: 25.606

First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.

1. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

2. Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement.

3. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.

4. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells.

5. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).

6. The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group.

7. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.

8. The MLL recombinome of acute leukemias in 2013.

9. Lineage switching in acute leukemias: a consequence of stem cell plasticity?

10. NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.

1. MLL-TET1 fusion protein promotes immortalization of myeloid progenitor cells and leukemia development.

2. The Impact of DNA Methylation in Hematopoietic Malignancies.

3. TET1 is a tumor suppressor of hematopoietic malignancy.

Review 4. Ten-eleven translocase: key regulator of the methylation landscape in cancer.

5. TRIB2 regulates the differentiation of MLL-TET1 transduced myeloid progenitor cells.

Review 6. TET proteins and 5-methylcytosine oxidation in hematological cancers.

7. A paradigm shift: lineage switch from T-ALL to B/myeloid MPAL.

8. TET proteins and the control of cytosine demethylation in cancer.

9. High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.

Review 10. Role of TET enzymes in DNA methylation, development, and cancer.